Boji Medical cancels stock options after expiration

Guangzhou Boji Medical & Biotechnological (SZSE:300404) announced the cancellation of 222,640 stock options that were not exercised during the second exercise period of its 2022 stock option incentive plan. This decision, approved by the board and supervisory committee on June 6, 2025, comes after the expiration of the second exercise window, during which some beneficiaries failed to fully utilize their allocated options. The cancellation aligns with the company's established procedures and will not materially impact Boji Medical's financial condition or operations. The company has previously cancelled options in 2022, 2023, 2024 and earlier in 2025 due to employee departures or unexercised allocations. Boji Medical's supervisory board has confirmed the cancellation adheres to the company's incentive plan rules, and the company intends to fulfil disclosure obligations.